Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "World-Health-Organization"

150 News Found

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


WHO Global Centre for Traditional Medicine to come up in Jamnagar
News | March 09, 2022

WHO Global Centre for Traditional Medicine to come up in Jamnagar

It will be the first and only global office for traditional medicine in the world


WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP
News | March 04, 2022

WHO and MPP welcome NIH’s offer of COVID-19 health technologies to C-TAP

Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements


USFDA refuses to grant EUA to Covaxin for padeatric use
News | March 04, 2022

USFDA refuses to grant EUA to Covaxin for padeatric use

Covaxin is not approved in the USA for any age group


WHO establishes biomanufacturing training hub in South Korea
News | February 23, 2022

WHO establishes biomanufacturing training hub in South Korea

Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


USFDA lifts clinical hold on submission of Covaxin
News | February 20, 2022

USFDA lifts clinical hold on submission of Covaxin

Covaxin is a whole-virion inactivated Covid-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades


WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients
Drug Approval | February 20, 2022

WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra


Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
News | February 14, 2022

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered


Thermo Fisher Scientific earns NSF/ANSI 456 vaccine storage certification
Medical Device | January 27, 2022

Thermo Fisher Scientific earns NSF/ANSI 456 vaccine storage certification

It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19